Analyst Viewpoint
Surge in demand for biopharmaceuticals and rise in adoption of personalized medicines are fueling the biopharmaceutical fermentation systems market size.
Regulatory bodies are encouraging the development of continuous processing for biopharmaceutical manufacturing thereby augmenting the demand for biopharmaceutical fermentation systems.
Rise in prevalence of cancer, autoimmune diseases, infectious diseases, and neurological disorders is likely to offer lucrative opportunities to vendors.
Manufacturers are adopting M&A strategies to expand their fermentation capacities and add additional capacities for recovery and purification processes. They are also providing pilot-to-commercial microbial fermentation capabilities, offering full support throughout the product’s life cycle.
Biopharmaceuticals can be produced utilizing continuous fermentations with microbial systems. Cell culture fermentation plays a crucial role in the development of new drugs. Therapeutic proteins, monoclonal antibodies, vaccines, and other complex molecules are produced using biopharmaceutical fermentation systems.
Microbial fermentation systems, mammalian cell culture systems, and plant cell culture systems are various types of biopharmaceutical fermentation systems.
Continuous biomanufacturing processes based on the application of continuous fermentation are employed in different industries including ethanol, lactic acid, and numerous biopharmaceutical productions. Bioprocessing for biopharmaceutical production involves a wide range of techniques.
The latest biopharmaceutical fermentation systems market trends are focused on increase in productivity, improvement in product quality, reduction in production costs, and enhanced scalability.
| Attribute | Detail |
|---|---|
| Drivers |
|
Biopharmaceuticals are widely employed in the treatment of various diseases including cancer, autoimmune diseases, infectious diseases, and neurological disorders. Monoclonal antibodies, checkpoint inhibitors, cytokines, and enzyme inhibitors are various types of biopharmaceuticals in cancer treatment.
A scientific paper published in the American Cancer Society journal estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. in 2022. Thus, rise in prevalence of cancer is expected to spur the biopharmaceutical fermentation systems market growth in the near future.
The biopharmaceutical sector is experiencing significant growth globally due to surge in geriatric population, increase in healthcare expenditure, and advancements in biotechnology research. Thus, expansion in biopharmaceutical sector is propelling the biopharmaceutical fermentation systems market development.
Fermentation systems enable the efficient production of complex biologics required for personalized medicines. Targeted therapies have shown potential in the treatment of various chronic diseases.
Biopharmaceutical fermentation systems are employed in the development of innovative and generic‐targeted biopharmaceuticals, including monoclonal antibodies, non‐antibody proteins, and small molecule drugs are used in the treatment of cancer.
R&D of next-generation therapies based on smaller biologic drug substances is driving the biopharmaceutical fermentation systems market value.
Fermentation systems are optimized to support the growth of microbial or mammalian cell cultures that produce small biologics. These systems help improve the production of smaller biologics. They offer better scalability, lower production costs, and faster production.
According to the latest biopharmaceutical fermentation systems market analysis, the recombinant proteins application segment dominated the industry in 2022.
Growth of the segment can be ascribed to the high dependence on microbial frameworks for the development of recombinant proteins. Large-scale production of recombinant proteins requires the growth of cells in fermentors.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America held largest share in 2022. Presence of leading biopharmaceutical companies and surge in R&D of biopharmaceuticals are driving the market dynamics of the region.
Increase in demand for biopharmaceuticals, growth in the prevalence of chronic diseases, and rise in healthcare expenditure are also contributing to the biopharmaceutical fermentation systems market share in the region.
Major manufacturers of biopharmaceutical fermentation systems are adopting M&A and product development strategies to expand their product portfolio.
GE Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius Stedim Biotech, Merck KGaA, Eppendorf AG, F. Hoffmann-La Roche Ltd., Nova Biomedical, Lonza Group AG, and BD are key players in the market.
The biopharmaceutical fermentation systems market report highlights these companies in terms of parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 23.4 Bn |
| Market Forecast Value in 2031 | US$ 52.6 Bn |
| Growth Rate (CAGR) | 9.5% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 23.4 Bn in 2022
It is projected to grow at a CAGR of 9.5% from 2023 to 2031
Surge in demand for biopharmaceuticals and rise in adoption of personalized medicines
The recombinant proteins application segment dominated in 2022
North America was the most lucrative region in 2022
GE Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius Stedim Biotech, Merck KGaA, Eppendorf AG, F. Hoffmann-La Roche Ltd., Nova Biomedical, Lonza Group AG, and BD
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Biopharmaceutical Fermentation Systems Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Upstream Products
6.3.1.1. Fermenters
6.3.1.2. Bioprocess Analyzers
6.3.1.3. Process Monitoring Devices
6.3.1.4. Culture & Media Preparation
6.3.1.5. Culture Media and Buffers & Inducers
6.3.1.6. Other Upstream Products
6.3.2. Downstream Products
6.3.2.1. Filtration & Separation Systems
6.3.2.2. Chromatography
6.3.2.3. Consumables & Accessories
6.3.2.4. Other Downstream Products
6.4. Market Attractiveness Analysis, by Product
7. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Recombinant Proteins
7.3.2. Monoclonal Antibodies
7.3.3. Antibiotics
7.3.4. Probiotics
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Biopharmaceutical Companies
8.3.2. Contract Manufacturing Organizations
8.3.3. Contract Research Organizations
8.3.4. Academic Research Institutes
8.3.5. Food Industry
8.3.6. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Biopharmaceutical Fermentation Systems Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Upstream Products
10.3.1.1. Fermenters
10.3.1.2. Bioprocess Analyzers
10.3.1.3. Process Monitoring Devices
10.3.1.4. Culture & Media Preparation
10.3.1.5. Culture Media and Buffers & Inducers
10.3.1.6. Other Upstream Products
10.3.2. Downstream Products
10.3.2.1. Filtration & Separation Systems
10.3.2.2. Chromatography
10.3.2.3. Consumables & Accessories
10.3.2.4. Other Downstream Products
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Recombinant Proteins
10.4.2. Monoclonal Antibodies
10.4.3. Antibiotics
10.4.4. Probiotics
10.4.5. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Biopharmaceutical Companies
10.5.2. Contract Manufacturing Organizations
10.5.3. Contract Research Organizations
10.5.4. Academic Research Institutes
10.5.5. Food Industry
10.5.6. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Biopharmaceutical Fermentation Systems Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Upstream Products
11.3.1.1. Fermenters
11.3.1.2. Bioprocess Analyzers
11.3.1.3. Process Monitoring Devices
11.3.1.4. Culture & Media Preparation
11.3.1.5. Culture Media and Buffers & Inducers
11.3.1.6. Other Upstream Products
11.3.2. Downstream Products
11.3.2.1. Filtration & Separation Systems
11.3.2.2. Chromatography
11.3.2.3. Consumables & Accessories
11.3.2.4. Other Downstream Products
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Recombinant Proteins
11.4.2. Monoclonal Antibodies
11.4.3. Antibiotics
11.4.4. Probiotics
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Biopharmaceutical Companies
11.5.2. Contract Manufacturing Organizations
11.5.3. Contract Research Organizations
11.5.4. Academic Research Institutes
11.5.5. Food Industry
11.5.6. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Biopharmaceutical Fermentation Systems Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Upstream Products
12.3.1.1. Fermenters
12.3.1.2. Bioprocess Analyzers
12.3.1.3. Process Monitoring Devices
12.3.1.4. Culture & Media Preparation
12.3.1.5. Culture Media and Buffers & Inducers
12.3.1.6. Other Upstream Products
12.3.2. Downstream Products
12.3.2.1. Filtration & Separation Systems
12.3.2.2. Chromatography
12.3.2.3. Consumables & Accessories
12.3.2.4. Other Downstream Products
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Recombinant Proteins
12.4.2. Monoclonal Antibodies
12.4.3. Antibiotics
12.4.4. Probiotics
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Biopharmaceutical Companies
12.5.2. Contract Manufacturing Organizations
12.5.3. Contract Research Organizations
12.5.4. Academic Research Institutes
12.5.5. Food Industry
12.5.6. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Biopharmaceutical Fermentation Systems Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Upstream Products
13.3.1.1. Fermenters
13.3.1.2. Bioprocess Analyzers
13.3.1.3. Process Monitoring Devices
13.3.1.4. Culture & Media Preparation
13.3.1.5. Culture Media and Buffers & Inducers
13.3.1.6. Other Upstream Products
13.3.2. Downstream Products
13.3.2.1. Filtration & Separation Systems
13.3.2.2. Chromatography
13.3.2.3. Consumables & Accessories
13.3.2.4. Other Downstream Products
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Recombinant Proteins
13.4.2. Monoclonal Antibodies
13.4.3. Antibiotics
13.4.4. Probiotics
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Biopharmaceutical Companies
13.5.2. Contract Manufacturing Organizations
13.5.3. Contract Research Organizations
13.5.4. Academic Research Institutes
13.5.5. Food Industry
13.5.6. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Biopharmaceutical Fermentation Systems Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2017–2031
14.3.1. Upstream Products
14.3.1.1. Fermenters
14.3.1.2. Bioprocess Analyzers
14.3.1.3. Process Monitoring Devices
14.3.1.4. Culture & Media Preparation
14.3.1.5. Culture Media and Buffers & Inducers
14.3.1.6. Other Upstream Products
14.3.2. Downstream Products
14.3.2.1. Filtration & Separation Systems
14.3.2.2. Chromatography
14.3.2.3. Consumables & Accessories
14.3.2.4. Other Downstream Products
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Recombinant Proteins
14.4.2. Monoclonal Antibodies
14.4.3. Antibiotics
14.4.4. Probiotics
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Biopharmaceutical Companies
14.5.2. Contract Manufacturing Organizations
14.5.3. Contract Research Organizations
14.5.4. Academic Research Institutes
14.5.5. Food Industry
14.5.6. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. GE Healthcare
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Thermo Fisher Scientific Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Danaher Corporation
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Sartorius Stedim Biotech
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. F. Hoffman-La Roche Ltd.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Eppendorf AG
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Merck KGaA
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Nova Biomedical
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Lonza Group AG
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. BD
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Biopharmaceutical Fermentation Systems Market Value Share, by Product, 2022
Figure 04: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn), by Application, 2022
Figure 05: Global Biopharmaceutical Fermentation Systems Market Value Share, by Application, 2022
Figure 06: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Biopharmaceutical Fermentation Systems Market Value Share, by End-user, 2022
Figure 08: Global Biopharmaceutical Fermentation Systems Market Value Share, by Region, 2022
Figure 09: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022–2031
Figure 11: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023–2031
Figure 12: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022–2031
Figure 13: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023–2031
Figure 14: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022–2031
Figure 15: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023–2031
Figure 16: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Region, 2022–2031
Figure 17: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Region, 2023–2031
Figure 18: North America Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country, 2022–2031
Figure 21: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022–2031
Figure 22: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022–2031
Figure 23: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022–2031
Figure 24: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023–2031
Figure 25: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023–2031
Figure 26: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 30: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022–2031
Figure 31: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022–2031
Figure 32: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022–2031
Figure 33: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023–2031
Figure 34: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023–2031
Figure 35: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 39: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022–2031
Figure 40: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022–2031
Figure 41: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022–2031
Figure 42: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023–2031
Figure 43: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023–2031
Figure 44: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 48: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022–2031
Figure 49: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022–2031
Figure 50: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022–2031
Figure 51: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023–2031
Figure 52: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023–2031
Figure 53: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 57: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022–2031
Figure 58: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022–2031
Figure 59: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022–2031
Figure 60: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023–2031
Figure 61: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023–2031
Figure 62: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Biopharmaceutical Fermentation Systems Market
*86 figures and 60 tables includes